Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study

© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. Objective: Tenofovir disoproxyl fumarate (TDF) disoproxyl fumarate (TDF) has in vitro activity against herpes simplex virus type 2 (HSV-2) and reduced HSV-2 acquisition as preexposure prophylaxis....

Full description

Saved in:
Bibliographic Details
Main Authors: Celum C., Hong T., Cent A., Donnell D., Morrow R., Baeten J., Firnhaber C., Grinsztejn B., Hosseinipour M., Lalloo U., Nyirenda M., Riviere C., Sanchez J., Santos B., Supparatpinyo K., Hakim J., Kumarasamy N., Campbell T.
Format: Journal
Published: 2017
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85019691645&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/40651
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Similar Items